Canada · Venture startup

Who invested in Gladius Pharmaceuticals

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$3.3Mraised across 2 rounds since 2015, from 2 sources

Latest round
VentureNov 2018
Biggest round
$3.3MSeries A · Jun 2015
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201620172018
$3.3MSeries A?Venture
First round
Series A, $3.3M
Jun 2015
Biggest round
$3.3M
Series A · Jun 2015
Between rounds
3.3 years
from the last two

The rounds

  1. Nov 2018
    VentureAmount undisclosed1 returning

    Source recordedSEC filing: $3.0M sold, first sale Nov 2018

  2. Jun 2015
    Series A$3.3M4 new

    From a historical funding recordSEC filing: $728K sold, first sale Jun 2015

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

SR OneCorporate VC2rounds
Lumira VenturesVC firm1round
GlaxoSmithKlineVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Gladius Pharmaceuticals

Who invested in Gladius Pharmaceuticals?

Gladius Pharmaceuticals's investors include SR One, Fonds de solidarite Ftq, Lumira Ventures and GlaxoSmithKline.

How much has Gladius Pharmaceuticals raised?

Gladius Pharmaceuticals has raised $3.3M across 2 rounds since 2015. One round did not disclose an amount, so the total is a floor.

When did Gladius Pharmaceuticals last raise?

Gladius Pharmaceuticals's most recent round was a Venture in Nov 2018.

What was Gladius Pharmaceuticals's biggest round?

Gladius Pharmaceuticals's largest round on record is $3.3M (Series A), in Jun 2015.

Who backed Gladius Pharmaceuticals first?

Gladius Pharmaceuticals's first round on record, in Jun 2015, was backed by SR One, Fonds de solidarite Ftq and Lumira Ventures and 1 others.

What stage is Gladius Pharmaceuticals at?

Gladius Pharmaceuticals's latest named round is a Venture, in Nov 2018.

Where is Gladius Pharmaceuticals based?

Gladius Pharmaceuticals is based in Canada.

Companies like Gladius Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.